Mirum Pharmaceuticals, Inc. (MIRM)
96.74
+0.44
(+0.45%)
USD |
NASDAQ |
Aug 24, 16:00
96.74
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Return Level : 96.31 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 96.31 |
| August 20, 2026 | 97.07 |
| August 19, 2026 | 102.24 |
| August 18, 2026 | 100.87 |
| August 17, 2026 | 99.83 |
| August 14, 2026 | 100.64 |
| August 13, 2026 | 98.77 |
| August 12, 2026 | 98.97 |
| August 11, 2026 | 98.23 |
| August 10, 2026 | 98.70 |
| August 07, 2026 | 100.65 |
| August 06, 2026 | 94.12 |
| August 05, 2026 | 105.79 |
| August 04, 2026 | 104.33 |
| August 03, 2026 | 104.59 |
| July 31, 2026 | 105.95 |
| July 30, 2026 | 112.59 |
| July 29, 2026 | 107.57 |
| July 28, 2026 | 112.23 |
| July 27, 2026 | 114.20 |
| July 24, 2026 | 113.03 |
| July 23, 2026 | 114.36 |
| July 22, 2026 | 114.48 |
| July 21, 2026 | 117.05 |
| July 20, 2026 | 116.62 |
| Date | Value |
|---|---|
| July 17, 2026 | 118.86 |
| July 16, 2026 | 117.36 |
| July 15, 2026 | 121.00 |
| July 14, 2026 | 120.89 |
| July 13, 2026 | 119.04 |
| July 10, 2026 | 122.13 |
| July 09, 2026 | 127.70 |
| July 08, 2026 | 128.57 |
| July 07, 2026 | 128.31 |
| July 06, 2026 | 121.91 |
| July 02, 2026 | 125.59 |
| July 01, 2026 | 120.46 |
| June 30, 2026 | 117.07 |
| June 29, 2026 | 123.00 |
| June 26, 2026 | 123.77 |
| June 25, 2026 | 117.28 |
| June 24, 2026 | 114.97 |
| June 23, 2026 | 111.07 |
| June 22, 2026 | 107.77 |
| June 18, 2026 | 107.13 |
| June 17, 2026 | 102.04 |
| June 16, 2026 | 101.55 |
| June 15, 2026 | 101.00 |
| June 12, 2026 | 99.34 |
| June 11, 2026 | 99.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Incyte Corp. | 127.81 |
| Insmed, Inc. | 125.77 |
| Alnylam Pharmaceuticals, Inc. | 236.22 |
| BioMarin Pharmaceutical, Inc. | 66.70 |
| Ionis Pharmaceuticals, Inc. | 59.74 |